Advertisement

Overview of the Development of Tumor Markers

  • K. B. Björklund
Conference paper

Abstract

The first attempt to apply bacteriological serology to the problem of malignant tumors was probably made in 1895 by Richet and Hericourt [1] at the Pasteur Institute in Paris. They immunized a donkey and two dogs with human osteosarcoma tissue and injected the resulting immune sera into patients, with no favorable results. Other attempts followed, and one investigator after another became interested in the search for antigens in cancer cells. Between 1895 and 1911 about 55 papers were published on the subject [2–7]. During the next 10 years, there was little interest in the pursuit of this type of research.

Keywords

Tumor Antigen Insoluble Residue Immune Seron Circulate Immune Complex Tissue Polypeptide Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Richet C, Hericourt J (1895) C R Acad Sc (Paris) 121:567Google Scholar
  2. 2.
    Ehrlich P (1908) Verh Dtsch Pathol Ges 12:13Google Scholar
  3. 3.
    Loeb L (1903) Virchows Arch Pathol Anat 172:345CrossRefGoogle Scholar
  4. 4.
    Schöne G (1906) MMW 53:2517Google Scholar
  5. 5.
    Bashford EJ, Murray JA, Cramer W (1908) 3rd Scientific Report of the Imperial Cancer Research Fund, p 315Google Scholar
  6. 6.
    Bridré J (1907) Ann Pasteur 21:760Google Scholar
  7. 7.
    Lambert RA, Hanes FM (1911) J Exp Med 13:505PubMedCrossRefGoogle Scholar
  8. 8.
    Lumsden T (1925) Lancet 208:383CrossRefGoogle Scholar
  9. 9.
    Lumsden T (1926) Lancet 211:112CrossRefGoogle Scholar
  10. 10.
    Lumsden T (1928) Arch Exp Zellforsch 6:206Google Scholar
  11. 11.
    Lumsden T (1931) Am J Cancer 15:563Google Scholar
  12. 12.
    Lumsden T (1931) J Pathol Bacteriol 34:349CrossRefGoogle Scholar
  13. 13.
    Woglom WH (1929) Cancer Rev 4:129Google Scholar
  14. 14.
    Lumsden T, Macrae T, Skipper E (1934) Lancet 226:721Google Scholar
  15. 15.
    Heidelberger M, Kendall FE (1929) J Exp Med 50:809PubMedCrossRefGoogle Scholar
  16. 16.
    Buchner H (1889) Zentralbl Bakteriol I Abt 5:817Google Scholar
  17. 17.
    Osborne TWB (1937) Complement or Alexin. Oxford University Press, LondonGoogle Scholar
  18. 18.
    Mayer MM, Osier AG, Bier OG, Heidelberger M (1946) J Exp Med 84:535PubMedCrossRefGoogle Scholar
  19. 19.
    Müller-Eberhard HJ (1975) Ann Rev Biochem 44:697PubMedCrossRefGoogle Scholar
  20. 20.
    Landsteiner K (1936) The specificity of serological reactions. Thomas, SpringfieldGoogle Scholar
  21. 21.
    Kabat EA (1966) J Immunol 97:1PubMedGoogle Scholar
  22. 22.
    Crumpton MJ (1974) Protein antigens: The molecular bases of antigenicity and immunogenicity. In: Sela M (ed) The antigens, vol II. Academic, New York, pp 1–78Google Scholar
  23. 23.
    Pressman D (1957) Ann NY Acad Sc 69:644CrossRefGoogle Scholar
  24. 24.
    Day ED, Barnes GW, Planisek JA, Pressman D (1958) JNCI 20:1123PubMedGoogle Scholar
  25. 25.
    Murray MR, Kopech G (1953) A bibliography of the research in tissue culture, 1884–1950, vol I, II, Academic, New YorkGoogle Scholar
  26. 26.
    Björklund B, Hellström L (1951) Acta Med Scand 139:122–132PubMedCrossRefGoogle Scholar
  27. 27.
    Björklund B (1953) Int Arch Allergy 4:340–359PubMedCrossRefGoogle Scholar
  28. 28.
    Björklund B (1953) Int Arch Allergy 4:379–414PubMedCrossRefGoogle Scholar
  29. 29.
    Greenstein JP (1954) Biochemistry of cancer. 2nd ed. Academic, New York, p 362Google Scholar
  30. 30.
    Boyd W (1947) A text-book of pathology. An introduction to medicine, 5th edn. Lea and Febiger, PhiladelphiaGoogle Scholar
  31. 31.
    Boyd W (1957) J Can Assoc Radiol 8:45–63Google Scholar
  32. 32.
    Everson TC, Cole WH (1956) Ann Surg 144:366PubMedCrossRefGoogle Scholar
  33. 33.
    Everson TC, Cole WH (1966) Spontaneous regression of cancer. Saunders, PhiladelphiaGoogle Scholar
  34. 34.
    Björklund B (1956) Int Arch Allergy 8:179–192PubMedCrossRefGoogle Scholar
  35. 35.
    Björklund B, Björklund V (1957) Int Arch Allergy 10:153–184PubMedCrossRefGoogle Scholar
  36. 36.
    Björklund B, Lundblad G, Björklund V (1958) Int Arch Allergy 12:241–261PubMedCrossRefGoogle Scholar
  37. 37.
    Björklund B, Paulsson JE (1962) Immunol 89:759–766Google Scholar
  38. 38.
    Björklund B (ed) (1973) Techniques for detection of cancer. Proceedings Folksam Symposium 1972. Bonniers, StockholmGoogle Scholar
  39. 39.
    Björklund B (1983) Tumor products reflecting growth activity. In: Stoll B (ed) Cancer treatment: end point evaluation. Wiley, Chichester, pp 251–278Google Scholar
  40. 40.
    Nathrath WBJ, Heidenkummer P, Björklund V, Björklund B (1985) J Histochem Cytochem 33(2):99–109PubMedCrossRefGoogle Scholar
  41. 41.
    Caselitz J, Seifert G, Björklund B, Björklund V (1983) Appl Pathol 1:115–120PubMedGoogle Scholar
  42. 42.
    Southam CM, Moore AE, Rhoads CP (1957) Science 125:158PubMedCrossRefGoogle Scholar
  43. 43.
    Southam CM (1958) Bull NY Acad Med 34:416Google Scholar
  44. 44.
    Southam CM, Moore AE Ann NY Acad Sci 73:635Google Scholar
  45. 45.
    Zilber LA (1958) Adv Cancer Res 5:291PubMedCrossRefGoogle Scholar
  46. 46.
    Zilber LA (1962) Ann NY Acad Sci 101:264CrossRefGoogle Scholar
  47. 47.
    Vygodchikov GW, Crawford R (eds) (1959) Pathogenesis and immunity of tumors. Pergamon, LondonGoogle Scholar
  48. 48.
    Lang N (1963) Med Welt 2538–2545Google Scholar
  49. 49.
    Day ED, Planisek JA, Pressman D (1961) JNCI 27:1107–1114PubMedGoogle Scholar
  50. 50.
    Buinauskas P, McCredie JA, Brown ER, Cole WH (1959) Arch Surg 79:432–439PubMedGoogle Scholar
  51. 51.
    Abramoff P, Saunders JW, Gasseling MT (1961) JNCI 26:585–599PubMedGoogle Scholar
  52. 52.
    Aizawa M, Southam CM (1960) Ann NY Acad Sci 87:293–307PubMedCrossRefGoogle Scholar
  53. 53.
    Bashkaev IS, Rosenbaum GI (1963) Vopr Oncol 9:83–87Google Scholar
  54. 54.
    Gorodilova VV, Shershul’skaia LV (1959) Specific antigens in malignant tumors of man. In: Vygodchikov GV (ed) Pathogenesis and immunology of tumors. Pergamon, New York, pp 101–112Google Scholar
  55. 55.
    Itoh T, Southam CM (1963) J Immunol 91:469–483PubMedGoogle Scholar
  56. 56.
    McKenna JM, Sanderson RP, Blakemore WS (1964) Cancer Res 24:754–762PubMedGoogle Scholar
  57. 57.
    Perez-Cuadrado S, Haberman S, Race GJ (1964) Dallas Med J 50:77–84Google Scholar
  58. 58.
    Hirai H, Taga H, Warabioka K (1964) J Biochem 55:178–184PubMedGoogle Scholar
  59. 59.
    Blaney DJ, Rotte TC, Siler VE (1964) Surg Gynecol Obstet 118:341–346PubMedGoogle Scholar
  60. 60.
    Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS (1963) Transplant Bull 1:174–180Google Scholar
  61. 61.
    Abelev GI (1968) Cancer Res 28:1344–1350PubMedGoogle Scholar
  62. 62.
    Talerman A (1981) Alpha-fetoprotein and germ cell tumors. In: von Kleist S, Breuer H (eds) Critical evaluation of tumor markers. Karger, BaselGoogle Scholar
  63. 63.
    Gold P, Freedman SO (1965) J Exp Med 121:439–462PubMedCrossRefGoogle Scholar
  64. 64.
    Gold P, Freedman SO (1965) J Exp Med 122:467–481PubMedCrossRefGoogle Scholar
  65. 65.
    Zamcheck N (1981) Clinical use of carcinoembryonic antigen. In: von Kleist S, Breuer H (eds) Critical evaluation of tumor markers. Karger, Basel, pp 25–38 (Contributions in oncology, vol 7)Google Scholar
  66. 66.
    Day ED (1965) The immunochemistry of cancer. Thomas, SpringfieldGoogle Scholar
  67. 67.
    Steinberg N et al. (1984) Am Gaster Assoc May, 1984Google Scholar
  68. 68.
    Bast et al. (1983) N Engl J Med 309(15):883–887PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • K. B. Björklund
    • 1
  1. 1.Cancer Immunology SectionThe National Bacteriological LaboratorySolna, StockholmSweden

Personalised recommendations